🎉🔬 #MC3Institute proudly hosted our 20th annual #MerkelCELLebration on 9/15—welcoming over 240 guests to learn more about the latest research & advances in #MCC treatment.

📖 Event recap: tinyurl.com/3zpkufm3
@uwmedicine.bsky.social @fredhutch.org
#cancerresearch #merkelcell

✈️ Emily Gong, former #MC3Institute undergrad research assistant, took her passion for research to France to study #Merkelcell carcinoma under Dr. Mahtab Samimi of the Université de Tours.

Keep Reading 👉 tinyurl.com/mr5x6dur
@uwmedicine.bsky.social @fredhutch.bsky.social

☀️🧴 With @obliteride.bsky.social coming up this Sat, we spent time selling popsicles & sunscreen to raise funds & build awareness around #Merkelcell carcinoma. #CureCancerFaster

🧡 Donate or Join Team 'Skin in The Game' tinyurl.com/obiteride-mc3

@fredhutch.bsky.social @uwmedicine.bsky.social

From the May 2025 issue: A gene to predict prognosis and metastasis in #merkelcell www.jidinnovations.org/article/S266... #IGF2BP3 #Carcinoma

Dr. Curtis Perry presented a rapid oral abstract on perturbational single-cell RNA sequencing of patient tumors in #merkelcell and small cell #lungcancer at #ASCO25 earlier this afternoon.
meetings.asco.org/abstracts-pr...
@yaleschoolofmed.bsky.social

🧡 🚴‍♀️ Support our team at the 2025 #Obliteride 5K run/walk! Every dollar raised goes directly to support #Merkelcell carcinoma research & clinical care. @fredhutch.bsky.social #curecancerfaster

🎉 Huge congratulations to Macy Gilmour, #MC3Institute undergrad research assistant, on being awarded a 2025 Mary Gates Research Scholarship!

🔗 mc3institute.uw.edu/news/macy-gilmour-awarded-gates-scholarship

#MaryGatesScholar #CancerResearch #merkelcell

The Merkel Cell Carcinoma Collaborative Institute launches, igniting a new era of research into a rare skin cancer UW Medicine launched the Merkel Cell Carcinoma Collaborative (MC3) Institute on Jan. 27 to cure an aggressive form of skin cancer.

📰 🔬 Huge thank you to @thedailyuw.bsky.social for covering the launch of the Merkel Cell Carcinoma Collaborative #MC3 Institute @uwmedicine.bsky.social/ @fredhutch.bsky.social! #merkelcell

IGF2BP3 as a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma Merkel cell carcinoma (MCC) is an aggressive skin cancer with frequent development of metastases, however effective treatment options for advanced disease are often missing. In this study, we investig...

A gene to predict prognosis and metastasis in #merkelcell www.jidinnovations.org/article/S266... #IGF2BP3 #Carcinoma

Today's blog post, the next in the cancer diary series, discusses missed signs of skin cancer.

msipressblog.blogspot.com/.../cancer-d....

#cancer #skincancer #merkelcell